Clinical Trial Update: Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life [Phase 2]

View source ↗

Summary

Phase 2 safety study of a monovalent high-dose inactivated poliovirus type 2 vaccine (m-IPV2 HD) in infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• monovalent high-dose inactivated poliovirus type 2 vaccine (m-IPV2 HD) (monovalent high-dose inactivated poliovirus type 2 vaccine)

Snippet

Sponsor: Vaxtrials S.A. | Conditions: Polio | Phase 2 | Status: COMPLETED